Study to Evaluate the Reduction of Cardiac Problems in Multiple Sclerosis Patients With Mitoxantrone and Dexrazoxane in Combination
Condition(s):Multiple SclerosisLast Updated:November 5, 2014Unknown status
Hide Studies Not Open or Pending
Condition(s):Multiple SclerosisLast Updated:November 5, 2014Unknown status
Condition(s):Recurrent/Refractory LymphomaLast Updated:December 30, 2021Completed
Condition(s):Advanced Pancreatic CancerLast Updated:October 29, 2021Not yet recruiting
Condition(s):Extranodal Natural Killer T Cell LymphomaLast Updated:July 19, 2022Recruiting
Condition(s):Relapsed and Refractory Peripheral T-cell LymphomaLast Updated:September 2, 2022Not yet recruiting
Condition(s):Unresectable or Metastatic Bone and Soft Tissue SarcomaLast Updated:March 7, 2024Terminated
Condition(s):Follicular LymphomaLast Updated:April 3, 2020Terminated
Condition(s):Treatment-naive or Relapsed or Refractory Acute Myeloid Leukemia (AML)Last Updated:October 29, 2021Unknown status
Condition(s):B-cell Acute Lymphoblastic Leukemia; B-cell Lymphoma RefractoryLast Updated:January 23, 2024Recruiting
Condition(s):Pediatric Solid TumorLast Updated:August 21, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.